Session Information
ENDO 2011 Annual Meeting
Click here to go to the previous page
Difficult Thyroid Cancer Cases
Track : CLINICAL
Program Code: MC1
Date: Sunday, June 5, 2011
Time: 12:15 PM to 1:00 PM  EST
Location: Grand Ballroom
SPEAKER (S):
R Michael Tuttle, MD, Mem Sloan Kettering Cancer Ctr
Disclosures: RMT: Research Funding, Genzyme Corporation; Consultant, Abbott Laboratories, Veracyte, Inc., Novo Nordisk.
Bryan Roland Haugen, MD, Univ of Colorado-Denver, Sch of Med
Disclosures: BRH: Speaker, Genzyme Corporation; Study Investigator, Veracyte, Inc.


Audio Synchronized to PowerPoint
(Code: MC1)
Attendee/Member-in-Training:
Attendee/Member:
Attendee/Non-Member:
Non-Attendee/Member-in-Training:
Non-Attendee/Member:
  
This session is a part of: